Main enrolled criteria:
Her2 insertion advanced NSCLC Her 2 amplification advanced NSCLC Failed with standard chemotherapy No history of PD-1/ PD-L1 antibody using
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
≥18，Advanced Non-squamous Non-small Cell Lung Cancer Confirmed by Histopathology
HER 2 Insertion or Amplification
First Diagnosis and Treatment
Treatment Plan is Chemotherapy or Chemotherapy plus PD-1 antibody
You may not be if
Patients received antitumor treatment before
Patients with contraindication of chemotherapy
Pregnant or breast feeding women
Clareo Health | Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC
